Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CKDSens

Financiado

Cerrado

A novel healthcare tool for the active ageing with chronic kidney disease

Frequent monitoring of the renal function is required for hundreds of millions of people (90m in the EU): patients suffering from chronic kidney disease (CKD), diabetes and cardiovascular problems. The monitoring of these patients... ver más

31/08/2019

CREATSENS HEALTH

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

CREATSENS HEALTH Mejorar el bienestar de las personas mediante el control de distintos parametros bioquimicos relevantes

TRL 3-4 | 168K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2019-08-31

EIC-SMEInst-2018-2020: SME instrument

I+D

Cerrada hace 7 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

CREATSENS HEALTH

50.00K€ | Lider

Proyectos interesantes

SYSKID

Medical Technol...

Data Science

16M€ Cerrado

U-Tube

Medical Technol...

Data Science

2M€ Cerrado

PRIME-CKD

Medical Technol...

Data Science

9M€ Cerrado

ELIMINATE-CKD

Medical Technol...

Data Science

2M€ Cerrado

DIGIPSYCHINCKD

Medical Technol...

Data Science

109K€ Cerrado

NEPHRON+

Medical Technol...

Data Science

7M€ Cerrado

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Duración del proyecto: 6 meses Fecha Inicio: 2019-02-05
Fecha Fin: 2019-08-31

Líder del proyecto

CREATSENS HEALTH Mejorar el bienestar de las personas mediante el control de distintos parametros bioquimicos relevantes

TRL 3-4 | 168K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Frequent monitoring of the renal function is required for hundreds of millions of people (90m in the EU): patients suffering from chronic kidney disease (CKD), diabetes and cardiovascular problems. The monitoring of these patients is still mostly done in hospitals, because the technology involved is too specialized to be handled by patients. Some companies offer limited qualitative monitoring in a near-patient care scenario, but quantitative monitoring is still centralized at hospitals. In this market, CDKSens can make a notable difference. CreatSens, a technology-based company from Spain, is developing a new point-of-care platform for the personalized management of the kidney function. CKDSens aims to improve current healthcare by introducing new synthetic membranes to detect several relevant biomarkers. CKDSens is a low-cost innovation requiring little expertise, ideal in a near-patient care scenario. By decentralizing the biomarkers’ analysis with new diagnostic systems (i.e. moving it from the hospital to the patient’s home), healthcare professionals will waste less time and money on analyses. This helps sustain our healthcare system. Individual patients will be able to lead a more active life, while health inequalities get tackled along the way. Direct stakeholders are pharmaceutical companies, technological healthcare companies and foundations. CreatSens wants to assess the technological and economic viability in the first 6 months (phase 1), to deliver a feasibility plan for phase 2 where the key steps for CreatSens to grow as a company in the European context will be introduced. CreatSens' 5-year growth plan is focused on selling the technology in 5 EU countries. We foresee 40 M€ turnover in the next 5 years, with the creation of 50 direct jobs and over 100 indirect jobs.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores